Search Results
Aug 04, 2026, 07:35 ET BV Investment Partners Announces Investment in Thomas & Company
Company, said, "This investment is a huge milestone for Thomas & Company and a very exciting day for our customers, employees, and partners. With BV's partnership, we are positioned to expand our client base, deepen our suite of services and continue investing in technology that simplifies complex
More news about: BV Investment Partners
Jul 09, 2026, 09:07 ET BEAULIEU VINEYARD OPENS NEW HOSPITALITY CENTER, MARKING A NEW ERA FOR ONE OF NAPA VALLEY'S FOUNDATIONAL WINERIES
Following a landmark, two-year renovation, BV's historic stone winery buildings have been restored and transformed into welcoming hospitality spaces designed to connect visitors more deeply with the
More news about: Beaulieu Vineyard
Jul 03, 2026, 12:24 ET Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders?
2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Bioventus Inc. (NASDAQ: BVS) breached their fiduciary duties to shareholders.
More news about: Halper Sadeh LLP
Jun 02, 2026, 09:00 ET The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
franchise grinding out margin gains — the commercialized end of the spectrum Conexeu sits at the opposite pole of.Bioventus Inc. (NASDAQ: BVS), a player in surgical solutions and restorative therapies, delivered the cleaner growth quarter. On May 6 it reported first-quarter revenue of about
More news about: Equity Insider
May 22, 2026, 10:31 ET Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
Conexeu Sciences Inc. (NASDAQ: CNXU), Integra LifeSciences Holdings Corporation (NASDAQ: IART), Evolus, Inc. (NASDAQ: EOLS), Bioventus Inc. (NASDAQ: BVS), Mesoblast Limited (NASDAQ: MESO)KEY TAKEAWAYSA fresh Nasdaq debut. Conexeu Sciences Inc. (Nasdaq: CNXU)
More news about: USA News Group
Apr 20, 2026, 12:13 ET BEAULIEU VINEYARD OPENS RESERVATIONS FOR NEW HOSPITALITY CENTER
designed to complement the wines and storytelling of the property. Constructed in the 1880s, the two-story structure long served as the center of BV's winemaking operations. The multi-year restoration, scheduled for completion in early July, is focused on preserving original materials and architectural
More news about: Beaulieu Vineyard
Apr 02, 2026, 07:30 ET BV Investment Partners Announces Sale of CallTower
South Jordan, Utah, CallTower serves over 80 countries from offices in Rochester, NY, London, Montreal and the Philippines.Since BV's investment in CallTower in 2023, CallTower strengthened its communications partnerships with key vendors, broadened routes to market, and expanded its
More news about: BV Investment Partners
Mar 10, 2026, 07:30 ET BV Investment Partners Announces Investment in Moxe Health
clinical data in a way that is trusted by providers and operationally effective for health plans," said Mike Coyne, Chief Executive Officer of Moxe. "With BV's partnership, we are positioned to accelerate our network expansion, deepen our embedded EHR relationships, and continue investing in technology that
More news about: BV Investment Partners
Jan 21, 2026, 09:24 ET BV Investment Partners Announces Launch of Altimeter Solutions Group Alongside Founding Team
Executive Officer of Altimeter Solutions Group, said, "I am thrilled to be partnering with BV Investment Partners on this transaction. With the support of BV's financial and strategic resources, Altimeter is exceptionally well positioned to pursue a growth strategy focused on scaling our technology-enabled
More news about: BV Investment Partners
Jan 06, 2026, 07:30 ET BV Investment Partners Announces the Raising of Fund XII At Its Hard Cap With $2.465 Billion Of Capital Commitments
Fall of 2025. The rapid capital raise and strong re-up rate from existing investors showcase BV's long-standing disciplined and focused strategy. Consistent with its predecessor funds, Fund XII will continue BV's established practice of investing alongside founders, management, and families to implement
More news about: BV Investment Partners
Dec 05, 2025, 15:30 ET HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Bioventus Inc. (NASDAQ: BVS) breached their fiduciary duties to shareholders.
More news about: Halper Sadeh LLP
Nov 10, 2025, 05:14 ET Exicom posts strong Q2 performance on solid India growth, charts a disciplined path for scale-up
the U.S. and Europe. In an important strategic move, Exicom BV's board has, in principle, approved up to $40 million for external financing
More news about: Exicom
Oct 29, 2025, 17:31 ET Postoperative Ileus Market to Advance Moderately During the Forecast Period (2025-2034) Owing to the Launch of Novel Therapies | DelveInsight
TU-100 (Tsumura USA), and others are currently under development to expand treatment choices. Orexa BV's ORE-001 is an oral formulation of lidocaine, aimed at enhancing appetite and supporting recovery in conditions like postoperative ileus, anorexia,
More news about: DelveInsight Business Research, LLP
Sep 17, 2025, 09:59 ET BAE Systems delivers BvS10s to Sweden, Germany, and the United Kingdom
presented three BvS10 Armored Personnel Carriers for Sweden, Germany, and the United Kingdom during a ceremonial delivery – providing their Armies with unrivalled mobility through the BvS10 Collaborative
More news about: BAE Systems, Inc.